Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study

BACKGROUND: New direct-acting antiviral therapies have revolutionized hepatitis C virus (HCV) infection therapy. Nonetheless, once liver cirrhosis is established, the risk of hepatocellular carcinoma (HCC) still exists despite virus eradication. Late HCV diagnosis hinders timely access to HCV treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Shen-Shong, Hu, Hsiao-Yun, Chen, Yu-Chin, Yen, Yung-Feng, Huang, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482748/
https://www.ncbi.nlm.nih.gov/pubmed/36115934
http://dx.doi.org/10.1186/s12876-022-02504-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482748/
https://www.ncbi.nlm.nih.gov/pubmed/36115934
http://dx.doi.org/10.1186/s12876-022-02504-6

Ejemplares similares